{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:44:25Z","timestamp":1782783865123,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R008051\/1"],"award-info":[{"award-number":["MR\/R008051\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024893","name":"Cambridge BHF Centre of Research Excellence","doi-asserted-by":"publisher","award":["RE\/18\/1\/34212"],"award-info":[{"award-number":["RE\/18\/1\/34212"]}],"id":[{"id":"10.13039\/501100024893","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome Trust ISSF"},{"DOI":"10.13039\/501100000374","name":"British Medical Association","doi-asserted-by":"crossref","award":["Josephine Lansdell Award"],"award-info":[{"award-number":["Josephine Lansdell Award"]}],"id":[{"id":"10.13039\/501100000374","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Association of Physicians of Great Britain and Ireland","award":["Young Investigator Award"],"award-info":[{"award-number":["Young Investigator Award"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03656-9","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:04:22Z","timestamp":1777331062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tracking the evolution of biomarker efficacy in SARS-CoV-2: a global meta-analyses series"],"prefix":"10.1186","volume":"27","author":[{"given":"ME Rahman","family":"Shuvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Schwiening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Avramidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Veale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A. Roger","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Samworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas W.","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm G.","family":"Semple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan J.","family":"Marciniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5744-5014","authenticated-orcid":false,"given":"Elaine","family":"Soon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"11","key":"3656_CR1","doi-asserted-by":"publisher","first-page":"e0241536","DOI":"10.1371\/journal.pone.0241536","volume":"15","author":"M Yanes-Lane","year":"2020","unstructured":"Yanes-Lane M, et al. Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: a systematic review and meta-analysis. PLoS ONE. 2020;15(11):e0241536.","journal-title":"PLoS ONE"},{"key":"3656_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jhin.2021.04.027","volume":"114","author":"A Bak","year":"2021","unstructured":"Bak A, et al. SARS-CoV-2 routes of transmission and recommendations for preventing acquisition: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance. J Hosp Infect. 2021;114:79\u2013103.","journal-title":"J Hosp Infect"},{"issue":"12","key":"3656_CR3","doi-asserted-by":"publisher","first-page":"e0244629","DOI":"10.1371\/journal.pone.0244629","volume":"15","author":"AA El-Solh","year":"2020","unstructured":"El-Solh AA, et al. Comparison of in-hospital mortality risk prediction models from COVID-19. PLoS ONE. 2020;15(12):e0244629.","journal-title":"PLoS ONE"},{"issue":"1","key":"3656_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.chest.2020.04.010","volume":"158","author":"R Chen","year":"2020","unstructured":"Chen R, et al. Risk factors of fatal outcome in hospitalized subjects with Coronavirus Disease 2019 from a nationwide analysis in China. Chest. 2020;158(1):97\u2013105.","journal-title":"Chest"},{"key":"3656_CR5","doi-asserted-by":"publisher","first-page":"100426","DOI":"10.1016\/j.eclinm.2020.100426","volume":"24","author":"Y Shang","year":"2020","unstructured":"Shang Y, et al. Scoring systems for predicting mortality for severe patients with COVID-19. EClinicalMedicine. 2020;24:100426.","journal-title":"EClinicalMedicine"},{"issue":"2","key":"3656_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.amepre.2020.05.002","volume":"59","author":"C Yu","year":"2020","unstructured":"Yu C, et al. Clinical characteristics, associated factors, and predicting COVID-19 mortality risk: a retrospective study in Wuhan. China Am J Prev Med. 2020;59(2):168\u201375.","journal-title":"China Am J Prev Med"},{"issue":"16","key":"3656_CR7","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1093\/cid\/ciaa538","volume":"71","author":"K Wang","year":"2020","unstructured":"Wang K, et al. Clinical and laboratory predictors of in-hospital mortality in patients with Coronavirus Disease-2019: a cohort study in Wuhan, China. Clin Infect Dis. 2020;71(16):2079\u201388.","journal-title":"Clin Infect Dis"},{"key":"3656_CR8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03498-2020","author":"RK Gupta","year":"2020","unstructured":"Gupta RK, et al. Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study. Eur Respir J. 2020. https:\/\/doi.org\/10.1183\/13993003.03498-2020.","journal-title":"Eur Respir J"},{"key":"3656_CR9","doi-asserted-by":"publisher","first-page":"m3339","DOI":"10.1136\/bmj.m3339","volume":"370","author":"SR Knight","year":"2020","unstructured":"Knight SR, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339.","journal-title":"BMJ"},{"issue":"1","key":"3656_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/sjmms.sjmms_480_21","volume":"10","author":"WT Aletreby","year":"2022","unstructured":"Aletreby WT, et al. External validation of 4C ISARIC Mortality Score in critically ill COVID-19 patients from Saudi Arabia. Saudi J Med Med Sci. 2022;10(1):19\u201324.","journal-title":"Saudi J Med Med Sci"},{"issue":"10","key":"3656_CR11","doi-asserted-by":"publisher","first-page":"e0274158","DOI":"10.1371\/journal.pone.0274158","volume":"17","author":"T Crocker-Buque","year":"2022","unstructured":"Crocker-Buque T, et al. Using ISARIC 4C mortality score to predict dynamic changes in mortality risk in COVID-19 patients during hospital admission. PLoS ONE. 2022;17(10):e0274158.","journal-title":"PLoS ONE"},{"issue":"8","key":"3656_CR12","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1007\/s12630-023-02512-4","volume":"70","author":"T Vallipuram","year":"2023","unstructured":"Vallipuram T, et al. External validation of the ISARIC 4C mortality score to predict in-hospital mortality among patients with COVID-19 in a Canadian intensive care unit: a single-centre historical cohort study. Can J Anaesth. 2023;70(8):1362\u201370.","journal-title":"Can J Anaesth"},{"issue":"1","key":"3656_CR13","doi-asserted-by":"publisher","first-page":"e874","DOI":"10.1093\/cid\/ciac087","volume":"75","author":"SWX Ong","year":"2022","unstructured":"Ong SWX, et al. Validation of ISARIC 4C mortality and deterioration scores in a mixed vaccination status cohort of hospitalized coronavirus disease 2019 (COVID-19) patients in Singapore. Clin Infect Dis. 2022;75(1):e874\u20137.","journal-title":"Clin Infect Dis"},{"key":"3656_CR14","doi-asserted-by":"crossref","unstructured":"Wang J, et al. Laboratory markers of severity across three COVID-19 outbreaks in Australia: has Omicron and vaccinations changed disease presentation? Intern Emerg Med. 2023;18(1):43-52.","DOI":"10.1007\/s11739-022-03081-y"},{"key":"3656_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10040557","author":"P Rzymski","year":"2022","unstructured":"Rzymski P, et al. Severe Breakthrough COVID-19 cases during six months of delta variant (B.1.617.2) Domination in Poland. Vaccines (Basel). 2022. https:\/\/doi.org\/10.3390\/vaccines10040557.","journal-title":"Vaccines (Basel)"},{"key":"3656_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijmmb.2022.12.004","volume":"41","author":"AK Patel","year":"2023","unstructured":"Patel AK, et al. COVID-19 patients\u2019 clinical profile and outcome with respect to their vaccination status: a prospective observational multicentre cohort study during third wave in Western India. Indian J Med Microbiol. 2023;41:28\u201332.","journal-title":"Indian J Med Microbiol"},{"issue":"4","key":"3656_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1556\/030.2022.01849","volume":"69","author":"SE Altintop","year":"2022","unstructured":"Altintop SE, et al. COVID-19 in elderly: correlations of viral load, clinical course, laboratory parameters, among patients vaccinated with CoronaVac. Acta Microbiol Immunol Hung. 2022;69(4):277\u201382.","journal-title":"Acta Microbiol Immunol Hung"},{"key":"3656_CR18","doi-asserted-by":"publisher","first-page":"1267991","DOI":"10.3389\/fimmu.2023.1267991","volume":"14","author":"JR Homen-Fernandez","year":"2023","unstructured":"Homen-Fernandez JR, et al. Differences in the inflammatory response among hospitalized patients with distinct variants of SARS-CoV-2. Front Immunol. 2023;14:1267991.","journal-title":"Front Immunol"},{"key":"3656_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041143","author":"G Meletis","year":"2023","unstructured":"Meletis G, et al. Variant-related differences in laboratory biomarkers among patients affected with alpha, delta and omicron: a retrospective whole viral genome sequencing and hospital-setting cohort study. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11041143.","journal-title":"Biomedicines"},{"key":"3656_CR20","doi-asserted-by":"publisher","first-page":"156367","DOI":"10.1016\/j.cyto.2023.156367","volume":"171","author":"F Azarfar","year":"2023","unstructured":"Azarfar F, et al. Investigation of the relationship between monocyte chemoattractant protein 1 rs1024611 variant and severity of COVID-19. Cytokine. 2023;171:156367.","journal-title":"Cytokine"},{"issue":"4","key":"3656_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2478\/jtim-2022-0054","volume":"10","author":"H Liu","year":"2022","unstructured":"Liu H, et al. Characteristics of the severe acute respiratory syndrome coronavirus 2 omicron BA.2 Subvariant in Jilin, China from march to May 2022. J Transl Int Med. 2022;10(4):349\u201358.","journal-title":"J Transl Int Med"},{"issue":"1","key":"3656_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10753-022-01734-w","volume":"46","author":"D Barh","year":"2023","unstructured":"Barh D, et al. SARS-CoV-2 variants show a gradual declining pathogenicity and pro-inflammatory cytokine stimulation, an increasing antigenic and anti-inflammatory cytokine induction, and rising structural protein instability: a minimal number genome-based approach. Inflammation. 2023;46(1):297\u2013312.","journal-title":"Inflammation"},{"key":"3656_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214146","author":"ZR Korobova","year":"2022","unstructured":"Korobova ZR, et al. Cytokine profiling in different SARS-CoV-2 genetic variants. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232214146.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3656_CR24","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41597-022-01534-9","volume":"9","author":"E Garcia-Gallo","year":"2022","unstructured":"Garcia-Gallo E, et al. ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19. Sci Data. 2022;9(1):454.","journal-title":"Sci Data"},{"issue":"7848","key":"3656_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","volume":"591","author":"E Pairo-Castineira","year":"2021","unstructured":"Pairo-Castineira E, et al. Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591(7848):92\u20138.","journal-title":"Nature"},{"issue":"1","key":"3656_CR26","doi-asserted-by":"publisher","first-page":"veac023","DOI":"10.1093\/ve\/veac023","volume":"8","author":"DW Wright","year":"2022","unstructured":"Wright DW, et al. Tracking SARS-CoV-2 mutations and variants through the COG-UK-Mutation Explorer. Virus Evol. 2022;8(1):veac023.","journal-title":"Virus Evol"},{"issue":"9","key":"3656_CR27","doi-asserted-by":"publisher","first-page":"e14426","DOI":"10.1111\/ijcp.14426","volume":"75","author":"L Marino","year":"2021","unstructured":"Marino L, et al. Time to hospitalisation, CT pulmonary involvement and in-hospital death in COVID-19 patients in an emergency medicine unit. Int J Clin Pract. 2021;75(9):e14426.","journal-title":"Int J Clin Pract"},{"issue":"11","key":"3656_CR28","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.cmi.2020.08.003","volume":"26","author":"M Bartoletti","year":"2020","unstructured":"Bartoletti M, et al. Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study). Clin Microbiol Infect. 2020;26(11):1545\u201353.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"3656_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s42256-020-0180-7","volume":"2","author":"L Yan","year":"2020","unstructured":"Yan L, et al. An interpretable mortality prediction model for COVID-19 patients. Nat Mach Intell. 2020;2(5):283\u20138.","journal-title":"Nat Mach Intell"},{"issue":"5","key":"3656_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thorax.58.5.377","volume":"58","author":"WS Lim","year":"2003","unstructured":"Lim WS, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377\u201382.","journal-title":"Thorax"},{"issue":"1","key":"3656_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.chest.2022.07.005","volume":"163","author":"C Cilloniz","year":"2023","unstructured":"Cilloniz C, et al. Machine-learning model for mortality prediction in patients with community-acquired pneumonia: development and validation study. Chest. 2023;163(1):77\u201388.","journal-title":"Chest"},{"issue":"3","key":"3656_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/thx.2006.067371","volume":"62","author":"G Barlow","year":"2007","unstructured":"Barlow G, Nathwani D, Davey P. The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax. 2007;62(3):253\u20139.","journal-title":"Thorax"},{"issue":"9","key":"3656_CR33","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/j.1469-0691.2009.02908.x","volume":"15","author":"M Parsonage","year":"2009","unstructured":"Parsonage M, et al. Evaluation of the performance of CURB-65 with increasing age. Clin Microbiol Infect. 2009;15(9):858\u201364.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"3656_CR34","doi-asserted-by":"publisher","first-page":"23878","DOI":"10.1038\/s41598-021-03440-3","volume":"11","author":"M Shirata","year":"2021","unstructured":"Shirata M, et al. Development and validation of a new scoring system for prognostic prediction of community-acquired pneumonia in older adults. Sci Rep. 2021;11(1):23878.","journal-title":"Sci Rep"},{"issue":"4","key":"3656_CR35","doi-asserted-by":"publisher","first-page":"e2044287","DOI":"10.25100\/cm.v52i4.4287","volume":"52","author":"C Hincapi\u00e9","year":"2021","unstructured":"Hincapi\u00e9 C, et al. Community-acquired pneumonia: comparison of three mortality prediction scores in the emergency department. Colomb Med (Cali). 2021;52(4):e2044287.","journal-title":"Colomb Med (Cali)"},{"issue":"1","key":"3656_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5334\/gh.1403","volume":"20","author":"JE G\u00f3mez-Mesa","year":"2025","unstructured":"G\u00f3mez-Mesa JE, et al. Marked global differences in mortality in male patients with COVID-19: an analysis of the CARDIO COVID 19-20 and WHF COVID-19 CVD studies. Glob Heart. 2025;20(1):21.","journal-title":"Glob Heart"},{"issue":"3","key":"3656_CR37","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/S2213-2600(20)30071-0","volume":"8","author":"J Zhang","year":"2020","unstructured":"Zhang J, et al. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics. Lancet Respir Med. 2020;8(3):e11\u20132.","journal-title":"Lancet Respir Med"},{"key":"3656_CR38","doi-asserted-by":"publisher","first-page":"m3520","DOI":"10.1136\/bmj.m3520","volume":"370","author":"G Iacobucci","year":"2020","unstructured":"Iacobucci G, Coombes R. Covid-19: government plans to spend \u00a3100bn on expanding testing to 10 million a day. BMJ. 2020;370:m3520.","journal-title":"BMJ"},{"issue":"8","key":"3656_CR39","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"Horby P, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704.","journal-title":"N Engl J Med"},{"issue":"2","key":"3656_CR40","doi-asserted-by":"publisher","first-page":"e0246318","DOI":"10.1371\/journal.pone.0246318","volume":"16","author":"R Chang","year":"2021","unstructured":"Chang R, et al. COVID-19 ICU and mechanical ventilation patient characteristics and outcomes-a systematic review and meta-analysis. PLoS ONE. 2021;16(2):e0246318.","journal-title":"PLoS ONE"},{"issue":"22","key":"3656_CR41","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.3390\/cancers14225490","volume":"14","author":"F Teglia","year":"2022","unstructured":"Teglia F, et al. Global Association of COVID-19 pandemic measures with cancer treatment: a systematic review and meta-analysis. Cancers. 2022;14(22):5490.","journal-title":"Cancers"},{"issue":"1","key":"3656_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S1473-3099(13)70327-X","volume":"14","author":"JW Dunning","year":"2014","unstructured":"Dunning JW, et al. Open source clinical science for emerging infections. Lancet Infect Dis. 2014;14(1):8\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"3656_CR43","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S1473-3099(20)30440-0","volume":"20","author":"Global outbreak research","year":"2020","unstructured":"Global outbreak research. harmony not hegemony. Lancet Infect Dis. 2020;20(7):770\u20132.","journal-title":"Lancet Infect Dis"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03656-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03656-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03656-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:52:51Z","timestamp":1782780771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03656-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3656"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03656-9","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the National Health System (UK) Health Research Authority via the Integrated Research Application System (reference 281880) for analysis of the Cambridge (UK) data, in accordance with the Declaration of Helsinki. All the other data has been published and\/or is in the public domain.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"265"}}